ARCT-032

· Arcturus Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARCT-032, covering 2024-11-13 to 2025-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis [Phase 2]